Adrimisin 50 Mg Lyophilized Powder For Injection Vial

Are you a Healthcare Professional?

The information in this section is intended for healthcare professionals and is not suitable for general use. Please confirm that you are a healthcare professional to continue.

Adrimisin 50 Mg Lyophilized Powder For Injection Vial

Product Features

Form For Injection Vial

Active Ingredient Doxorubicin hydrochloride

Therapeutic Area Oncology and Hematology

Summary of Product Characteristics (SPC)

View on Map

+90 212 692 9292

[email protected]

A member of

Last Update: 16/06/2026

Home

About Us

Our Policies

Quality Policy
Information Security Policy

Products

Contact

Drug Safety and Adverse Event Reporting Information Society Services Terms of Use & Privacy Personal Data Protection

As SABA HOLDİNG ANONİM ŞİRKETİ, we use cookies on our website to improve its functionality and provide you with a better experience.
For more information on how we use cookies, you can read our Cookie Information Notice and withdraw your optional consent for the use of relevant cookie categories at any time from the "Cookie Settings" section.

Necessary Cookies

Certain cookies are required for our website to function properly.

Functional Cookies

These cookies remember your preferences and choices made on the website to provide a more personalized experience.

Performance/Analytics Cookies

These cookies help us understand how visitors interact with our website by collecting usage information.

Advertising / Marketing Cookies

These cookies collect information about users to serve relevant content and advertisements based on their interests.